| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 11 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Australia | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Podack Eckhard R | 17 |
| #2 | Schreiber Taylor H | 3 |
| #3 | Khan Samia Q | 3 |
| #4 | Schreiber Taylor | 3 |
| #5 | Deyev Vadim | 2 |
| #6 | Yamazaki Koichi | 2 |
| #7 | Strbo Natasa | 2 |
| #8 | Rosenblatt Joseph D | 1 |
| #9 | Spielman Julie | 1 |
| #10 | Fang Lei | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2015131176A1 | Compositions, methods, and kits for treatment of cancer | |
| WO2014110258A1 | Compositions and methods for the regulation of t regulatory cells using tl1a-ig fusion protein | |
| US2014286991A1 | Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv | |
| US2011287057A1 | Cancer Treatment | |
| US2012029472A1 | Tnfr25 agonists to enhance immune responses to vaccines | |
| US2011195048A1 | Regulation of lymphocytes and uses therefor |